Amiodarone has become an important drug for the treatment of supraventricular and ventricular arrhythmias, in short-term inpatient and outpatient settings. It may also have a role in affecting outcome in patients at high risk for arrhythmic events and sudden death; its place among available therapies is being established in clinical trials.
Goldschlager N, Epstein AE, Naccarelli G, Olshansky B, Singh B, for the Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology. Practical Guidelines for Clinicians Who Treat Patients With Amiodarone. Arch Intern Med. 2000;160(12):1741–1748. doi:10.1001/archinte.160.12.1741
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: